Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and abstention.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
St.helen (2020)
Neuromodulatory and neurotoxic effects of e-cigarette vapor using a realistic exposure method.
Nonclinical
Other Diseases
Staal (2023)
adolescent electronic cigarette use and tobacco smoking in the Millennium Cohort Study.
Population Clinical
Consumer Use
Youth Use & Appeal
Staff (2022)
Characterization of Total and Unprotonated (Free) Nicotine Content of Nicotine Pouch Products
Non-Clinical
Chemical
Analysis
Stanfill (2021)
Longitudinal transitions of exclusive and polytobacco electronic nicotine delivery systems (ENDS) use among youth, young adults and adults in the USa: findings from the PaTh Study Waves 1-3 (2013-2016).
Population Clinical
Consumer Use
Youth Use & Appeal
Stanton (2020)
Longitudinal associations between U.S. youth exposure to E-cigarette marketing and E-cigarette use harm perception and behavior change.
Population Clinical
Effect Of Packaging & Labelling On Perception Of Risk
Stanton (2022)
Toxicology of flavoring- and cannabis-containing e-liquids used in electronic delivery systems.
Nonclinical
ALL
Stefaniak (2021)
Influence of E-Liquid humectants, Nicotine, and Flavorings on aerosol Particle Size Distribution and Implications for Modeling Respiratory Deposition.
Nonclinical
Chemical
Analysis
Stefaniak (2022)
Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke
Non-Clinical
Carcinogenicity
In Vitro
Stephens (2017)
a targeted approach to using e-cigarettes for harm reduction in adults.
Population Clinical
Cessation
Tobacco
Stevens (2022)